3AQ-31148-94912 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-06-24
Dose 1 — Moderna
2021-07-24
Dose 2 — Moderna
2021-07-26
Registered in v-safe
2021-07-26
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tiredness, Diarrhea

Adult check-in
2021-07-27
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Itching · Fatigue or tiredness

Adult check-in
2021-08-02
Health check-in — day 7, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-08-12
Survey response — day 14, dose 2
MedDRA: Dyspnoea — Feeling: Fair · Be unable to do your normal daily activities

Free text: Difficulty breathing

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-16
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2022-01-22
Survey response — 6 months, dose 2
MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities

Free text: Headaches

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-06-24	Moderna	No
2	2021-07-24	Moderna	No

Free text

Release 9 — day 14, dose 2

2021-08-12

Symptoms: Difficulty breathing

Release 11 — 6 months, dose 2

2022-01-22

Symptoms: Headaches

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dyspnoea	✓	·	✓
SD	Headache	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release